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Abbreviations 
 
ANC  Absolute neutrophil counts 
AUC  Area under the curve 
BPD  Bronchopulmonary dysplasia 
BW   Birth weight 
C3  Complement component 3 
C5a  Complement component 5a 
CBC  Complete blood count 
CD64  Cluster of Differentiation 64 
CoNS  Coagulase-negative Staphylococci 
CRP  C reactive protein 
CSF  Cerebrospinal fluid 
CVC  Central venous catheter 
DIC  Disseminated intravascular coagulation 
DOL  Day of life 
ELBW Extremely low birth weight 
EOS  Early-onset sepsis 
GA  Gestational age 
GNR  Gram-negative rod 
GPC  Gram-positive cocci 
I:T  Immature-to-total neutrophil 
IgG  Immunoglobulin G  
IL  Interleukin 
LBW Low birth weight 
LOS  Late-onset sepsis 
NEC  Necrotizing enterocolitis 
NICHD  National Institute of Child Health 
NICU  Neonatal intensive care units  
NPV  Negative predictive value 
PAMP  Pathogen-associated molecular patterns 
PCT  Procalcitonin 
PDA  Patent ductus arteriosus 
PPV  Positive predictive value 
SAA  Serum amyloid A 
SD  Standard deviation 
SIRS  Systemic inflammatory response syndrome 
TLR  Toll like receptors 
TNF-α  Tumor necrosis factor-α 
VLBW Very low birth weight 
WBC  White blood cell 
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1.0 Summary 
 
Title: DIAGNOSTIC CRITERIA FOR LATE NEONATAL SEPSIS 
Author: Gustaf Sebastian Edström 
Late-onset neonatal sepsis is one of the leading causes of morbidity and mortality in 
neonates. Late-onset sepsis is usually defined as sepsis >72 hours after birth. Low birth 
weight and gestational age are inversely related to the development of late-onset sepsis. 
Gram-positive organisms appear to be the cause of the majority of the infections. 
Particularly coagulase-negative staphylococci have been implicated in late-onset neonatal 
sepsis. The pathophysiological mechanisms underlying the development of sepsis is a 
complex interaction between the invading pathogen and the neonate’s immune system. 
Diagnosing late-onset sepsis is extremely challenging due to unspecific symptoms and 
clinical signs which frequently can mimic other non-infectious etiologies. Blood cultures 
are time consuming and often yield false negative results. Markers and laboratory test 
used in the evaluation, such as white blood cell count, absolute neutrophil counts, 
immature-to-total neutrophil ratio, C-reactive protein, procalcitonin, tumor necrosis 
factor-α, serum amyloid A, IL-6, IL-8 and CD64 have been used to assist in the 
identification of late-onset sepsis. However, at present time no marker is individually 
sufficient to confirm the diagnosis. Usage of two or more markers with different 
properties, also measured in different time intervals often leads to increased diagnostic 
accuracy. This could be helpful for the clinicians in the diagnosis and management of 
late-onset sepsis. There are several novel biomarkers under investigation that appear 
promising for the future. 
 
Keywords: Neonatal Late-Onset Sepsis  Diagnosis  Newborn  Infection  Cytokines 
  
 6 
2.0 Sažetak 
Naslov: DIJAGNOSTICIČKI KRITERIJI ZA KASNU NOVOROĐENAČKU SEPSU 
 
Autor: Gustaf Sebastian Edström 
Pojava kasne novorođenačke sepse je jedan od vodećih uzroka smrtnosti novorođenčadi. 
Kasna novorođenačka sepsa obično se definira kao sepsa koja nastaje nakon više od 
sedamdesetdva sata poslije rođenja. Niske težine novorođenčadi i gestacijska dob su 
obrnuto povezane s nastupom ove sepse. Čini se da su gram-pozitivni organizmi, a 
posebice koagulaza negativni stafilokoki, najčesći uzročnici infekcija koje vode u 
novorođenačku sepsu. Patofiziološki mehanizmi iza nastanka sepse, su složena 
interakcija između patogena i imunološkog sustava novorođenčeta. Dijagnosticiranje 
kasne novorođenačke sepse je iznimno zahtjevno zbog nespecifičnih simptoma i kliničkih 
znakova koji često mogu oponašati druga neinfektivna stanja. Bakterijske hemokulture 
uzimaju vremena i često su lažno negativne. Postoji vise markera i laboratorijskih 
testova, kao što su broj bijelih krvnih stanica, apsolutni broj neutrofila, omjer ukupnih 
neutrofila, C-reaktivni protein, prokalcitonin, čimbenik nekroze tumora, serum amiloid 
A, IL-6, IL- 8 i CD64 koji se koriste u postavljanju dijagnoze kasne novorođenačke 
sepse. Međutim, trenutno nema specifičnih markera za pouzdano postavljanje dijagnoze. 
Kombiniranje dva ili više markera s različitim svojstvima koji su uzeti u različitim 
vremenskim razmacima, povećava dijagnostičku točnost. To bi moglo biti korisno za 
kliničare i u dijagnozi i liječenju kasne novorođenačke sepse. U toku su istraživanja na 
više različitih markera sa obećavajućim izgledima. 
 
Ključne riječi: Kasna novorođenačka sepsa   Dijagnoza  Novorođenčad  Infekcija   
Citokini  
 7 
3.0 Introduction 
 
Late-onset neonatal sepsis (LOS) is a life-threatening event in the neonatal period and in 
the rest of infancy. There are inherent difficulties with diagnosing neonatal sepsis early 
due to the non-specific presentation, which leads to increased morbidity and mortality. 
The warning signs could easily be confused with other non-infectious causes. Blood 
culture is the gold standard for diagnosis of neonatal sepsis but is time consuming. It 
takes approximately 48 to 72 hours to obtain results and false negatives are troublesome 
as bacteraemia is often low in concentration and sporadic. This is further expressed with 
low volume samples and antibiotic treatment prior to blood culture (1). In turn, this leads 
to limited sensitivity of the blood culture (2). The signs of sepsis such as fever or 
hypothermia, tachycardia, hypotonia and lethargy are unspecific and can easily be 
mistaken for other non-infectious conditions. Currently there are no adequate specific 
markers for diagnosis of neonatal sepsis. The most used biomarkers such as C-reactive 
protein (CRP), white blood cell count, total neutrophil count and Immature-to-Total 
neutrophil (I:T) ratio are valuable for guidance, but none has shown to be sufficient in 
diagnosing sepsis (3). Nevertheless, there are many promising biomarkers that are 
currently being explored. A sensitive and specific biomarker could guide clinicians in 
deciding whether to start antibiotic treatment or not, and if the continuation with 
antibiotics is necessary. To determine if a laboratory test is clinically useful, it should rise 
rapidly and have a good diagnostic window. The ideal biomarker should have a well-
defined cut-off value, with sensitivity and negative predictive value (NPV) approaching 
100% to be able to rule out neonatal sepsis. The specificity and positive predictive value 
(PPV) should also be >85% (4). 
 This review focuses on late-onset neonatal sepsis with approaches toward 
aetiology, risk factors, clinical features and laboratory markers. Hopefully this could help 
to the development of diagnostic criteria that could help diagnosing LOS, in order to 
reduce the morbidity and mortality connected with neonatal sepsis. 
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4.0 Definitions and Classification 
 
The clinical condition of neonatal sepsis is classified according to postnatal age. There 
are slight variations in the exact time frame used for classification. The most commonly 
used classification defines early-onset neonatal sepsis (EOS) as infection ≤ 72 hours of 
life and late-onset neonatal sepsis (LOS) >72 hours to 7 days of life (1, 5, 6).  One study 
used the age of the neonate when a positive blood culture was obtained and then 
classified further into early-onset (≤ 4 days), late-onset (5-30 days) and late, late-onset 
(>30 days) (7). There are other studies that extend the days of life (DOL) and define LOS 
from 4 days to 120 days of life (8, 9). There are also studies that define neonatal infection 
proven by blood culture as EOS (<7 days or <72 hours in case of VLBW) and LOS (>7 
days after delivery) (10). 
Classification of the pediatric age group can sometimes be confusing and terms 
can occasionally be used interchangeably, like neonate and infant. For the purpose of this 
paper we use the age group defined by European medical agency in 2010 at the consensus 
conference that states neonates is defined as birth to less than 1 month, and defining 
infants as 1 month to less than 2 years (11).  
 Neonatal sepsis starts with infection in the newborn. This primary event can in 
some individuals develop further into a systemic inflammatory response syndrome 
(SIRS). SIRS with suspected or proven infection constitutes the definition of sepsis (12).  
The definition of systemic inflammatory response syndrome is classically defined by: 
fever or hypothermia, tachycardia, tachypnea or hyperventilation, and abnormally high or 
low white blood cell count. Importantly, two or more of these variables need to be present 
to be able to diagnose SIRS (6, 13).  Due to the inherent problems of diagnosing neonatal 
sepsis and in making the definition of SIRS more applicable to the pediatric age group, a 
consensus definition of SIRS was developed with some changes. Currently the criteria 
requires two out of four criteria, with one of them being abnormal temperature (>38,5°C 
or <36°C) or abnormal leukocyte count (increased or decreased for age or >10% 
immature neutrophils). The other two criteria’s are tachycardia (>2 SD above normal age) 
or bradycardia (<10
th
 percentile for age) and increased mean respiratory rate  (>2 SD 
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above for normal age) (14). The term “SIRS” was developed to describe the nonspecific 
inflammatory process occurring after infection, but also from non-infectious causes (15). 
Non-infectious causes in the newborn period that could develop into SIRS are traumatic 
delivery, asphyxia, inborn errors of metabolism and surgical procedures among others 
(16). 
Severe sepsis is described if the newborn has sepsis and cardiovascular 
dysfunction or acute respiratory distress syndrome or ≥2 other organs dysfunctions (14). 
Sepsis could be seen as an order of phases starting with infection leading to SIRS and 
hence sepsis. If deterioration progresses, this could result in severe sepsis, and later septic 
shock with multiple organ failure and eventually death. It could be problematic to 
determine the current phase that is present in a patient as a change between phases could 
occur quickly (17). Generally if there is cardiovascular dysfunction that cannot be 
resolved with initial fluid therapy this signifies septic shock (18).  
5.0 Epidemiology 
 
Around 135 million children are borne yearly, with infection (36%) in the 
neonatal period being the single largest cause of death worldwide (19). Sepsis in 
developing countries is estimated to cause 30-50% of total neonatal deaths (20). The 
incidence of LOS in hospitalised newborns is estimated to be from 0.61% to 14.2% with 
variations geographically (21). In The United States and Australasia the incidence of LOS 
is up to 6 per 1000 births (22). Even with the usage of antimicrobial treatment 39% of 
cases of neonatal sepsis result in death or major disability (12). Neonatal mortality is 
presumably to be under-reported by 20% in developing countries (22). 
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6.0 Pathophysiology 
 
The consensus conference in 1991 established the definitions of sepsis. It is defined  as a 
condition that results from infection leading the host developing systemic inflammatory 
response syndrome (SIRS) (15). The interaction between the host complement system 
and the pathogen causes the release of pro-inflammatory mediators including C3 and C5a 
which leads to vasodilatation, chemotaxis and the release of cytokines Interleukin (IL) 1, 
IL 6, IL 8. In addition, the coagulation cascade is excessively activated, natural 
anticoagulants inhibited and fibrinolysis suppressed which in combination leads to an 
increased risk of microthrombi and consequential local cellular hypoxia (23, 24). 
Ultimately this culminates in end organ damage and dysfunction. Disseminated 
intravascular coagulation (DIC) is not rare in septic shock. Petechiae, ecchymoses and 
hemorrhages can also be observed due to consumption of coagulation factors and 
platelets (17).  
The pathogens have different pathogen-associated molecular patterns (PAMPs) 
that are recognized by the host innate immune system, more specifically the Toll-like 
receptors (TLR). Toll-like receptors are membrane bound receptors that have a 
fundamental role in the pathophysiology of sepsis and septic shock. Upon activation of 
TLR, nucleus activation occurs and transcription of genes that induce pro-inflammatory 
and anti-inflammatory mediators, particularly cytokines ensues (16). The cytokine 
response to sepsis in neonates compared to adults is faster and more prominent. 
Meanwhile, the compensatory anti-inflammatory system in neonates appears to be 
immature, this is seen in both term and preterm neonates. Polymorphonuclear 
neutrophils, macrophages and eosinophils also have imperfect opsonization, phagocytosis 
and antigen presenting properties, which leads to reduced response by the neonatal 
immune system (17).  
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7.0 Ethiopathogenesis 
 
 7.1 Risk factors 
 
There are several factors that contribute and interact to increase the probability of 
developing late neonatal sepsis. With decreasing birth weight (BW) and gestational age 
(GA) there is an increase in the incidence of late-onset neonatal sepsis, showing an 
inverse relationship between birth weight and gestational age (25). In one study from The 
National Institute of Child Health (NICHD) and Human Development Neonatal Research 
Network it was shown that neonates with BW of 401 g to 750 g had a 43% risk of late-
onset sepsis. For BW of 751 g to 1000 g the risk was 28%, BW 1001 g to 1250 g had a 
15% risk and neonates with BW 1251 g to 1500 g a 7% risk of LOS. In respect to 
gestational age, a comparable relationship can be made with neonates born < 25 weeks 
gestation, which had an incidence of 46% for LOS. There was a decline to 29% for GA 
between 25 to 28 weeks, and further to 10% at 29 to 32 weeks. Neonates born after 32 
weeks had 2% incidence of LOS (26).  
With prolonged hospitalizations due to decreased BW, GA and other medical 
conditions, the usage of central venous lines (CVC) for administrating antimicrobials, 
parental nutrition and other medicines is not uncommon, but CVC itself is a risk factor 
for developing LOS (27). CVCs can cause a blood stream infection either from 
intraluminal or extraluminal contamination. Intraluminal contamination results either 
from contaminated intravenous fluids or catheter hub. Organisms colonizing the skin can 
travel along the catheter and to cause extraluminal contamination. This can be identified 
with isolation of the same organism in blood as on the tip of the catheter (28). 
Furthermore, patients that are on mechanical ventilators for respiratory support 
also have an increased risk for LOS (26). The endotracheal tube may provide a site of 
entry of organisms into the respiratory tract and later cause a systemic infection. 
Mechanical trauma to the endotracheal mucosa during suctioning may further contribute 
to infection due to breaking the anatomical barrier (29). Transient bacteraemia around 
five minutes after suctioning has been performed has been shown in neonates (30). 
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Total parental nutrition (TPN) has also been identified as a risk factor with 
particular precaution to the duration of TPN in the development of LOS (31). Lack of 
enteral feeding has been linked with the development of candidiasis as well as the usage 
of cephalosporins (32). Patent ductus arteriosus (PDA), bronchopulmonary dysplasia 
(BPD) and necrotizing enterocolitis (NEC) require supplementary interventions such as 
mechanical ventilation, CVCs and prolonged parenteral nutrition which leads to added 
risk factors for LOS (26, 33). 
 
 7.2 Pathogens 
 
Classification of neonatal sepsis into early-onset (EOS) and late-onset neonatal sepsis 
(LOS) is based on different timing (7). As aforementioned, in classification different 
authors use slightly different timing to define the EOS and LOS. Regardless what specific 
timing is used, the classification was created to imply the different mode of transmission 
and different microorganisms associated with EOS and LOS, and to help in choosing the 
appropriate antibiotic treatment (34). EOS is associated with transmission from the 
mother during the intrapartum period and thus typically reflects vertical transmission 
(35). LOS on the other hand, is seemingly acquired postnatally from environmental 
sources (36). 
  The predominant pathogens implicated in LOS are gram-positive organisms, 
accounting for between 45 to 77% of the infections, with coagulase-negative 
Staphylococci (CoNS) being the most prevalent (28). The National Institute of Child 
Health and Human Development Neonatal Research Network reported in a study on 6215 
admitted neonates that CoNS accounted for 48% of all first time infections. The other 
gram-positive organisms included Staphylococcus aureus (7.8%), Enterococcus spp. 
(3.3%) and group B Streptococcus (2.3%). Gram-negative organisms constituted 18% of 
infections where Escherichia coli, Klebsiella, Pseudomonas, Enterobacter and Serratia 
were most prevalent. Fungal organism accounted for a total of 12% and Candida albicans 
was the most encountered of the fungi (26).  
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Gram-negative organisms are less commonly a causative factor in the 
development of neonatal sepsis, albeit they have been associated with a higher mortality 
(28). Roughly one-third of cases of LOS are due to gram-negative infections, 
nevertheless, 40-69% of the deaths associated with neonatal sepsis can be attributed to 
gram-negative organisms (37). Of the infections caused by Pseudomonas aeruginosa 
several investigators reported mortality rates around 40% (8).  
 Coagulase-negative Staphylococci are unable to produce free coagulase which 
differentiates it from other types of Staphylococci. Out of the CoNS, Staphylococcus 
epidermidis is the principal microbiological organism that has been implicated in LOS in 
VLBW neonates. In industrialized countries it has been associated with up to 77.9% of all 
cases of LOS and 46.5% in developing regions (38). Staphylococcus epidermidis is 
capable of adhering and proliferating on plastic surfaces of indwelling catheters due to its 
capability to create multi-layered agglomerations termed biofilms. The biofilms cause 
problems both for the antibiotics and the immune system to attack the microorganism 
(10). Normally, Staphylococcus epidermidis is found on the skin and on mucous 
membranes and does not cause harm to healthy tissue. Colonization by Staphylococcus 
epidermidis in the neonatal period has also been indicated as beneficial to the host by 
educating the innate immune system and inhibiting virulent microorganisms (38, 39). 
 Out of the Candida family the Candida albicans and Candida parapsilosis species 
are the most common in neonates. Collectively the Candida species are the third leading 
cause of LOS in premature infants. Candida’s ability to express certain virulence traits as 
adherence factors and cytotoxic substances has been associated with higher mortality rate 
and neurodevelopmental impairment (37). 
 Cohen-Wolkowiez et al showed the relationship between incidence of LOS with 
DOL and organism involved (Figure 1). In their study the distribution of organism 
implicated in LOS changed little depending on DOL but the incidence of LOS increased 
with DOL (8). 
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Figure 1. Infection episodes by organism group and postnatal age among late preterm infants with late 
onset sepsis. From Cohen-Wolkowiez et al (8).  
 
8.0 Diagnostics 
 
 8.1 Clinical features 
 
The clinical presentation of neonatal sepsis varies tremendously making it difficult to 
diagnose and the signs are often non-specific. The presenting sign are often variable and 
can also reflect non-infectious etiologies (6). Depending on the virulence of the pathogen 
and the host’s immune system response there will also be an unpredictable clinical 
presentation. The immune system in premature neonates is also immature, leading to 
misleading signs and symptoms (10). 
Normal range for heart rate, respiratory rate and systolic blood pressure in 
neonates was developed from the International Consensus Conference on Pediatric Sepsis 
in 2005. The values can be seen in table 1 below. 
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Table 1. Modified from International Consensus Conference on Pediatric Sepsis. 
International pediatric sepsis consensus conference: definition for sepsis and organ 
dysfunction in pediatrics (14). 
Age Group  Heart Rate (bpm) Respiratory Rate 
(breaths/min) 
Systolic Blood 
Pressure (mmHg) 
0 to 7 days 100 to 180 >50 <65 
7 to 28 days 100 to 180 >40 <75 
1 mo to 12mo  90 to 180 >34 <100 
 
Clinical signs and symptoms are very variable, but most common include 
temperature instability, respiratory distress, apnea, cyanosis, bradycardia, tachycardia 
bulging fontanels, seizures, jaundice and feeding intolerance among others. Skin lesions 
could also be present and include cutaneous and mucosal petechial, impetigo, cellulitis 
and abscesses (10, 37). Motor functions are frequently diminished and initially the first 
symptoms might only be a neonate with lethargy or poor feeding (6). Fanaroff et al did a 
study on a total 2416 infants, 395 with culture-proven sepsis. They investigated the 
incidence, clinical presentation and risk factors for LOS in low birth weight infants. The 
main clinical features reported included increased apnea (55%), abdominal distension or 
guaiac-positive stool (43%), increased respiratory demand (29%), lethargy and hypotonia 
(23%) and feeding intolerance (25) 
 
 8.2 Laboratory findings 
 
With fundamental difficulties to diagnose LOS based on solely clinical features, the quest 
for finding a marker that has sufficient sensitivity and specificity has been extensive. To 
date the definitive diagnosis still requires isolation of the pathogen from a normally 
sterile area, including blood and cerebrospinal fluid (CSF). Therefore in a suspected case 
of neonatal sepsis blood should be drawn (1 mL is recommended) and also lumbar 
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puncture should be considered (6).  However, the results from culture can takes 24 to 48 
hours before being obtained and the results can be false-negative especially if influenced 
by maternal antibiotic use or patients’ antibiotic use (40). To decrease the excessive 
usage of antibiotics, several markers have been studied. Ng and Lam summarized the 
current view on the ideal biomarker for use in LOS and concluded that the biomarker 
should possess the following properties (4): 
1. Well-defined cut off values, sensitivity and NPV approaching 100% for 
“ruling out” LOS. And specificity and PPV of  >85%. 
2. Detection of infection early 
3. Be pathogen specific (e.g. viral, bacterial and fungal) 
4. Help in antibiotic guidance and in monitoring disease progression 
5. Predict severity 
6. Predict prognosis 
7. Require small volume of specimen, stable in laboratory, quick turnaround 
time, inexpensive. 
There is a vast array of biomarkers studied that have been implicated in LOS, mostly 
acute phase reactants, cytokines and cell-surface antigens have been reviewed. 
 Complete blood count (CBC) 
Complete blood count (CBC) is widely accessible, rapid and relatively economical. A 
survey of neonatal intensive care units (NICU) showed that 99% of the NICU do obtain 
CBC count during the initial evaluation for LOS (41). Most frequently the white blood 
cell (WBC) count and differential with indices alike absolute neutrophil counts (ANC) 
and immature-to-total neutrophil (I:T) ratio are used to aid in the diagnosis of LOS. 
Although they are highly related to the timing of the sample and other non-infectious 
causes, this creates a very wide range of indices (42). Different pathogens could also 
induce different response, Gram-negative organisms seems to elevate the I:T ratio more 
than Gram-positive organisms (43).  
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 C reactive protein (CRP) 
CRP is an acute-phase reactant that has a vital role in the humoral reaction to bacteria. It 
is widely available, cost-effective, fast and comprehensively studied as a biomarker in 
neonatal sepsis (44). Infection leads to release of IL-6 together with other pro-
inflammatory cytokines that causes de novo CRP hepatic synthesis. CRP is released 4 to 
6 hours after the onset of infection and peaks at around 48 hours. This in turn activates 
the complement system, monocytes, increase phagocytosis and increases the production 
of other proinflammatory cytokines (45). Generally, CRP is considered rather 
nonspecific, particularly in the adult population due to many non-infectious causes, such 
as rheumatoid arthritis and inflammatory bowel disease, which could be the cause of a 
rising CRP. Nevertheless, in neonates a significant rise in CRP has a narrower spectrum 
of diagnoses that could be responsible for its elevation (4). 
 Procalcitonin (PCT) 
Hepatocytes and monocytes are the main producers of PCT, that is a part of the acute 
phase reactants. PCT is a peptide prohormone of calcitonin and has been studied as a 
marker to differentiate non-infectious diseases from sepsis (46). In response to 
endotoxins it is seemingly released form hepatocytes and circulating macrophages. After 
4 hours of exposure to bacterial endotoxins serum PCT begins to rise and reaches a peak 
in 6 to 8 hours. It then remains elevated for a minimum of 24 hours (47). The rise in 
serum concentration of PCT after infection is also faster when compared to CRP (3). In 
neonates however, there is a physiological postnatal increase of PCT, which is evident in 
both healthy term and preterm neonates with wide variations (40).  
 Serum amyloid A (SAA) 
Serum amyloid A is an acute phase reactant produced mainly from hepatic synthesis but 
also from smooth muscle cells, macrophages and endothelial cells. It is regulated by 
proinflammatory cytokines such as IL-6 and TNF-α. SAA has been reported to increase 
up to 1000 fold after the onset of inflammation (48, 49). SAA has been shown to be a 
useful marker in many conditions such as bacterial or viral infections, trauma and also 
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neonatal sepsis (48). Precisely how SAA works has not been established, but multiple 
functions have been attributed to SAA. For example SAA is involved in 
immunomodulatory actions, is a chemoattractant for monocytes and activates 
collagenases that aid in tissue regeneration (50). 
 Cytokines 
Several cytokines have been established to increase during response to neonatal infection. 
The increase of cytokines in neonatal sepsis occurs fast, even before the rise in acute 
phase reactants and the development of clinical signs (34). The most studied cytokines 
include Interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), IL-6 and IL-8. They are 
produced by a variety of cells like monocytes, endothelial cells and lymphocytes (51).  
 IL-6 is secreted rapidly in response to endotoxins, reaching its peak within 2-3 
hours, followed by a rapid decline at around 6-8 hours and later a return to baseline by 24 
hours (52). Il-6 induces hepatic production of CRP leading to the rise of IL-6 levels 
before CRP (53). Due to this feature, IL-6 is suitable for very early warning of sepsis, but 
due to the short half-life and uncertainty of knowing when the sample was drawn, Il-6 
should not be relied on as the sole marker (53). In neonates with clinical sepsis or proven 
sepsis, IL-6 concentrations are significantly elevated compared to non-infected neonates 
(54). In a meta-analysis performed of 13 publications IL-6 revealed a pooled sensitivity 
and specificity of 79% and 84% respectively for neonatal sepsis (55).  
IL-8 has comparable kinetics as IL-6 and has a part in chemotaxis and activation and 
migration of granulocytes (1). The levels of IL-8 increase 1-3 hours after infection and 
the half-life is less than 4 hours (56). A meta-analysis on IL-8 showed moderate accuracy 
in diagnosis of neonatal sepsis with a pooled sensitivity and specificity of 78% and 84%, 
respectively (56). IL-8 has also been shown to also be associated with the severity of 
infection and thus not merely beneficial as a marker of sepsis (57). TNF-α is also part of 
the cytokines that make up the acute phase reaction. The serum concentration of TNF-α 
has shown to be increased in infected neonates when compared to non-infected neonates 
(53). 
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 Cluster of Differentiation 64 (CD64) 
Bacterial infection causes the up-regulation of leukocyte antigen that can be measured by 
flow cytometry. There are several advantages with using flow cytometry such as the 
requirement of a small volume of blood; the turnaround time is fast and there is a wide 
window for blood sampling. The disadvantages however, are that flow cytometry is 
usually not considered as a part of routine the evaluation in NICU and the process 
requires skilled technicians to be performed (4). The cell-surface antigen CD64 is present 
on neutrophil the surface, and is one of the three high-affinity antibody Fcy receptors. 
During sepsis inflammatory cytokines stimulate a quantitative up-regulation of CD64. 
This causes gradual increase in surface density and a stable expression of over 24 hours 
(58). Upon binding of immunoglobulin G (IgG) to CD64, phagocytosis and intracellular 
killing of opsonized microbes is enhanced. As opsonization requires encapsulated 
bacteria, no increase in expression of CD64 will be seen during viral infection. This up-
regulation of CD64 is detected 1 to 6 hours after bacterial invasion (59). Up-regulation of 
CD64 has also shown to be an independent risk factor for developing LOS (60). A meta-
analysis from 2013 consisting of 12 studies with a total of 1915 neonates showed a 
sensitivity of 78% and specificity of 81% in the diagnosis of neonatal sepsis with CD64 
as a single test (61). 
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9.0 Discussion 
 
 9.1 What group of neonates have an increased risk of LOS? 
 
VLBW neonates have an increased risk of developing LOS, generally the risk of 
developing LOS is inversely related to the gestational age and to the birth weight. The 
NICHD Neonatal Research Network showed data of birth weight and gestational age in 
correlation with infection and the highest rates revealed that neonates of 401 g to 705 g 
had a 43% risk of infection and 46% for less than 25 weeks gestation (62). This relates 
partly to the circumstance that less mature neonates and neonates of low birth weight 
require longer hospitalizations, mechanical ventilation, central venous access and 
parenteral nutrition, resulting in greater exposure to nosocomial infections and 
consequently increased risk of LOS (63). Bizzaro et al reported the incidence of EOS and 
LOS in relation to birth weight. As seen in table 2 there is an increase in sepsis per 1000 
births with lower birth weight and it is more common for neonates of low birth weight to 
develop LOS compared to EOS (7). 
 
Table 2. Birth weight-specific Sepsis rates for Newborns. Table modified from Bizzaro et 
al.(7). EOS- early-onset sepsis, LOS- Late-onset sepsis, ELBW- extremely low birth 
weight, VLBW- very low birth weight, LBW- Low birth weight. 
Birth weight (g) Sepsis, Cases /1000 births Births 
 
 
EOS LOS Total 
ELBW <1000 54,5 441,8 496,3 
VLBW 1499-1000 14,8 79,2 94 
LBW ≥1500 3,52 23,43 26,95 
Total 72,82 544,43 617,25 
 
Some studies have presented that exposure to antenatal steroids has been shown to 
reduce the incidence of EOS, but on the other hand to increase the incidence of LOS (10). 
Although there seems to be conflicting evidence, Helen et al showed no increased risk of 
LOS in their study of combined use of maternal corticosteroid and antibiotic use (64). 
Nonetheless, the use of antenatal steroids should be balanced against the beneficial 
effects such as decrease risk of death, intraventricular haemorrhage and respiratory 
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distress syndrome (62). More studies are necessary on antenatal steroid use to draw any 
conclusion in the relationship to LOS. 
Central venous catheters (CVCs) may provide an opportunity for interventions in 
LOS, though it is also contributing to LOS acting as a source of infection. Gaynes et al 
reported that blood stream infections were the most common nosocomial infection in all 
birth weights and that 88% were associated with umbilical or central venous catheters 
(65). Furthermore a cohort study showed that intraluminal contamination of CVCs 
accounted for 67% and extraluminal for 20% of the bloodstream infections (66). Hoffman 
et al presented in a cohort study that peripheral inserted central catheters removed due to 
adverse events were significant associated with LOS and that antibiotic usage before 
removal does not decrease the sepsis rate (67). The time length which a CVC could be 
kept before replacing it with a new one has also been of concern, but in a study of 135 
cases of catheter related infection in the NICU, increasing dwell time was not linked with 
an increased infection rate and this could be due to decreased need of other invasive 
devices, improved nutrition and maturation of infants’ immune system (68).  
The low pH in the stomach is considered a protective mechanism against bacteria 
and antacids used in neonates could by raising the gastric pH decrease this defence. 
Terrin et al revealed that ranitidine was indeed associated with an increased risk of 
infections in VLBW infants (69). Singh et al evaluated 360 VLBW neonates, 64 whom 
received ranitidine and/or omeprazole. In their study they did not show any statically 
significant difference in the incidence of LOS (70). Noticeably there is conflicting 
evidence and more studies are needed to draw any definite conclusions. Several authors 
still recommend caution when prescribing antacids to neonates. 
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Mechanical ventilation is also a well-recognized risk factor for developing 
nosocomial infection, but also any type of respiratory tract device, tracheal intubation, 
nasopharyngeal and nasal cannula are associated with an increased risk (71). One study 
from Stoll et al showed that in neonates that were ventilated for more than 28 days, half 
of the neonates developed LOS compared to only 9% of those on ventilator for less than 
7 days (26). When endotracheal suctioning is necessary, this must be performed gently to 
minimise the risk of breakage of the tracheal mucosa (29).  
 
9.2 How could lab help with the diagnosis of LOS? 
 
Serum biomarkers mostly investigated to aid in the diagnosis of LOS are either key 
proinflammatory or anti-inflammatory mediators involved in the inflammatory and 
infectious cascade. To date there is no single laboratory marker that satisfactorily 
diagnoses LOS. This relates to that many of the biomarkers are influenced by other 
factors than sepsis. Non-infectious conditions for example surgery or tissue injury also 
affects the biomarkers. Normal ranges are hard to establish due to the fluctuation in 
neonates. Often this leads to delayed diagnosis, excessive therapy, increased costs and 
emergence of resistant organisms. This leads to the possibility of combining two or more 
biomarkers and hence increases the sensitivity and specificity (4, 10).  
CBC is commonly used in the initial evaluation of LOS, while it is difficult to 
interpret early in life because of the fluctuations with day of life and gestational age (37). 
Hornik et al reports an association between high or low WBC counts, high ANC, high I:T 
ratio and low platelet counts with LOS. The highest specificity was for WBC (99%) 
either <1000/    or >50,000/   . With increasing postnatal age at the time of culture 
the associations became weaker. Even though these markers are associated with infection 
the sensitivity of these findings was low but the specificity was generally high, therefore 
no CBC count can sufficiently and reliably rule out LOS (9). 
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Of the acute phase proteins, CRP is studied extensively and used for diagnosis 
and monitoring of treatment. One problem of using CRP in the early days of life is the 
nonspecific physiological 3-day rise in CRP. This is due to stress during delivery and 
other maternal and perinatal factors. In the early stages of infection CRP has a low 
sensitivity due to delayed hepatic production (72). Several different cut-off values for 
CRP have been used, two studies with a cut-off value of 12 mg/L measured on the day of 
sepsis evaluation showed a sensitivity of 60% and 65% respectively and a specificity of 
96% and 99% respectively. However after 24 hours both studies reported an increase in 
the sensitivity for CRP with a sensitivity of 82% and 72% respectively, the specificity 
was 96% and 100% after 24 hours respectively (53, 73). Hotoura et al used a cut-off 
value of 10 mg/L and also reported a good specificity of 90%, although the sensitivity 
was 68% (74). Higher cut-off values have been used; Terrin et al reported a sensitivity 
and specificity of 29% and 93% respectively in a study with 231 neonates using the cut-
off value of 100 mg/L (75). To further increase the sensitivity the usage of serial 
measurements of CRP could be employed at 24-48 hours after onset of symptoms to 
increases the sensitivity (76, 77). Serial measurements of CRP are good for ruling out 
sepsis and normal levels for >48 hours could aid in the decision whether to continue or 
discontinue with antibiotic treatment (4). Another acute phase protein commonly 
implicated in LOS is serum amyloid A (SAA). SAA has shown to be a good prognostic 
marker in LOS. When comparing to CRP and WBC as a prognostic marker SAA is the 
earliest marker of LOS (78). Arnon et al reported that SAA is an accurate marker in the 
diagnosis of LOS at the first suspicion on sepsis. They reported that it was more sensitive 
marker for differentiating sepsis from non-sepsis preterm infants compared to CRP and 
IL-6, concluding that SAA could be used as an early marker for detection of LOS (79). 
Conversely, another studied focusing on SAA as a diagnostic marker during LOS, did not 
show any statistical significance (80). In a meta-analysis by Yuan et al involving 823 
neonates (8-96 hours after infection), SAA showed moderate accuracy in diagnosing 
neonatal sepsis, the pooled sensitivity was 78% and the pooled specificity was 92% (81). 
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Procalcitonin has shown promising results. It has been suggested for usage in the 
international definition of sepsis (82). In one meta-analysis by Vouloumanou et al, a 
better diagnostic accuracy was reported comparing LOS to EOS when using PCT. They 
found the area under the curve (AUC) to be 0.95. The sensitivity of PCT for diagnosing 
LOS was 90% and the specificity was 88%. However they are highlighting that they did 
not have sufficient data for a well-founded conclusion (40). Yu et al showed in their 
meta-analysis on PCT, that PCT had moderate accuracy diagnosing neonatal sepsis but 
PCT had better accuracy than CRP in the diagnosis of LOS. Other studies have also 
reported better sensitivity and specificity, ranging from 87% to 100% with PCT 
compared to CRP and other acute phase proteins (83). A meta-analysis by Bokun Lv et al 
on TNF-α with 15 articles and 23 trials presented moderate accuracy with sensitivity of 
68% and specificity of 89% for LOS. They also reported higher diagnostic accuracy for 
LOS compared to EOS when using TNF-α (84). Bokun Lv et al also compared PCT with 
TNF-α in their study and reported that the pooled specificity was 89% for TNF-α versus 
77% for PCT, although the pooled sensitivity was marginally lower for TNF-α when 
compared to PCT (84). Ucar et al compared PCT, SAA, CRP and TNF-α and reported 
that CRP was the best reliable marker of inflammation aimed at diagnosing LOS, then 
PCT > TNF-α > SAA (80). 
Interleukins are encouraging in the diagnosis of LOS. They are generally 
considered to be sensitive for neonatal sepsis. They can be detected in the blood early, but 
do have a short half-life which limit their clinical use (10). Ng et al studied IL-6 and used 
a cut-off value of 31 pg/mL and reported a sensitivity of 78% and a specificity of 92% at 
the time of evaluation of LOS. They found that 24 hours after the sensitivity and 
specificity was 44% and 93% respectively afterwards (73). Hotoura et al reported with a 
cut-off value of 30 pg/ml a sensitivity of 100% and a specificity of 74% using IL-6 (74). 
Another interleukin studied in diagnosis of LOS is IL-8, which has similar kinetics as IL-
6 (1).  
 
 
 25 
 
In a study by Boskabadi et al, IL-8 was measured in 93 neonates of ≥72 hours of 
age. The serum concentrations of IL-8 were 3.3 times higher in non-surviving neonates 
compared to surviving neonates. They also reported a sensitivity of 95% and a specificity 
of 100% using a cut-off value of 60 pg/ml, signifying that IL-8 could be a valid early 
predictive marker in diagnosing LOS (57). 
Several different cell-surface antigens have been studied in neonates in the 
context of neonatal sepsis (85). CD64 seems to be the most promising in diagnosing LOS 
(86, 87). One study by Ng et al on CD64 investigating 80 infants showed a sensitivity of 
95-97% and a negative predictive value of 97-99% at the time of sepsis evaluation and 24 
hours after the onset. If combining CD64 with either IL-6 or CRP at the time of sepsis 
evaluation and CD64 at 24 hours the specificity was 88% and the positive predictive 
value was 80% (73). Other studies using different cut-off values reported different data. 
Mazzucchelli et al used 2.85 as cut-off reported a sensitivity of 87.5% and specificity of 
100% for CD64 index used in culture proven LOS (86). Streimish et al used a cut-off 
value of 3.62 and demonstrated a sensitivity of 75%, specificity of 77% and negative 
predictive value of 96% (87). 
The use of a combination of two or more markers has been studied; preferably to 
overcome one markers’ disadvantage and in that way complement each other. Ng et al 
combined IL-6 and CRP on day 0 (day of sepsis evaluation) and TNF-α on day 1 or CRP 
on day 2 and presented a sensitivity and specificity of 98%, 91% respectively for 
diagnosing LOS (53). The biomarkers could also be categorized into early (IL-6, IL-8 
CD64), mid (PCT) and late phase (CRP) based on the detection time after infection (88). 
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10.0 Conclusion 
 
Late-onset neonatal sepsis has been and still is today a significant cause of morbidity and 
mortality, both in developing and developed countries. The risk factors are various and 
numerous, however preterm birth and low birth weight leads to prolonged hospital stay in 
a high-risk environment. Together they are the cornerstones in the development of late-
onset neonatal sepsis. The combination of an indefinable clinical presentation that often 
resembles a wide array of conditions with biomarkers that is not sufficient to rule out or 
to rule in late-onset sepsis. There is a need for a biomarker that could reliable diagnose 
late-onset neonatal sepsis. Several biomarkers or combinations are promising, but larger 
studies are needed to be able to safely confirm late-onset sepsis. Of the studies available 
CRP and PCT seem promising. The use of multiple biomarkers such as IL-6 or CRP on 
the day of sepsis evaluation, and after 24 hours the use TNF-α has presented good 
sensitivity and specificity. Several new studies are in progress, in the research of potential 
novel markers that could revolutionize the diagnosis of late-onset neonatal sepsis in the 
future. In the meantime, suspicion to late-onset neonatal sepsis should relay on the 
presence of a wide spectrum of risk factors, unspecific signs of clinical presentation, 
different combination of laboratory (including microbiology) investigation, and on the 
response to antimicrobial and other, supportive treatment.  
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